Neha Patel in Lees Summit, Missouri

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2009
The Primary Medical Specialty for Neha Patel is listed as: Allergy/immunology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 6507168838
NPI #: 1184921421
NPI Created On: 02/23/2011
NPI Last Updated Listed as: 03/15/2021
Primary Taxonomy Code: 207RA0201X
License Number:
2014022153
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medica Insurance Company
• Celtic Insurance Company
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Gujarati.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Blood test, comprehensive group of blood chemicals
3. Creatine kinase (cardiac enzyme) level
4. Gammaglobulin (immune system protein) measurement
5. Uric acid level, blood
6. Complete blood cell count (red cells, white blood cell, platelets), automated test
7. Red blood cell sedimentation rate, to detect inflammation
8. Measurement c-reactive protein for detection of infection or inflammation
9. Injection of allergenic extracts into skin, accessed through the skin
10. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
11. Infusion into a vein for therapy, prevention, or diagnosis
12. Infusion of chemotherapy into a vein up to 1 hour
13. Infusion of chemotherapy into a vein
14. New patient office or other outpatient visit, typically 45 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
18. Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
19. Injection, infliximab, excludes biosimilar, 10 mg
20. Injection, tocilizumab, 1 mg